Status:
COMPLETED
Genetic Counseling in Women at Risk for BRCA1 or BRCA2 Mutations
Lead Sponsor:
Georgetown University
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Breast Cancer
Eligibility:
FEMALE
25-75 years
Phase:
NA
Brief Summary
RATIONALE: Genetic counseling and using an interactive computer program may help women at risk for breast cancer make medical decisions about treatment. PURPOSE: This randomized clinical trial is stu...
Detailed Description
OBJECTIVES: * Evaluate the impact of BRCA1/BRCA2 testing among members of hereditary breast-ovarian cancer families. * Evaluate the long-term impact of genetic counseling and testing on psychosocial ...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Members of hereditary breast/ovarian cancer families (in which there is at least a 10-20% prior probability of a BRCA1/2 mutation) OR who have a first-degree relative with a known BRCA1 or BRCA2 mutation
- Prior diagnosis of breast cancer allowed
- Must not be undergoing active treatment
- Patients with prior bilateral mastectomy are eligible for study but not eligible for randomization
- PATIENT CHARACTERISTICS:
- Female only
- No psychiatric or cognitive disorder that would preclude giving informed consent
- PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Exclusion
Key Trial Info
Start Date :
December 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
1109 Patients enrolled
Trial Details
Trial ID
NCT00416754
Start Date
December 1 2000
End Date
December 1 2006
Last Update
April 7 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.